A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples